ZyVersa Therapeutics, Inc. (ZVSA) › Cash & EquivalentsZyVersa Therapeutics, Inc. (ZVSA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.Fiscal YearCash & EquivalentsChange YoY2021$928.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share